We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.1B
AUM Growth
+$1.4B
(+11%)
Cap. Flow
-$4.28B
Cap. Flow
% of AUM
-30.25%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$61M |
| 2 |
RTX Corp
RTX
|
+$38.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.5M |
| 4 |
Delta Air Lines
DAL
|
+$14.5M |
| 5 |
SWT
Stanley Black & Decker, Inc.
SWT
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$578M |
| 2 |
AGN
Allergan plc
AGN
|
+$67M |
| 3 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$51.1M |
| 4 |
Alibaba
BABA
|
+$46.8M |
| 5 |
lululemon athletica
LULU
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.91% |
| 2 | Healthcare | 8.15% |
| 3 | Consumer Discretionary | 7.49% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HES
126
DELISTED
Hess
HES
| $21.4M | 0.15% |
413,528
+119,246
| +41% | +$5.46M |
|
127
CALL
Wells Fargo
WFC
$264B
| $21.1M | 0.15% |
+825,000
| New | +$22.6M |
|
128
Chubb
CB
$139B
| $20.7M | 0.15% |
163,678
+18,123
| +12% | +$2.1M |
|
129
Starbucks
SBUX
$118B
| $20.5M | 0.15% |
279,193
-187,010
| -40% | -$14.1M |
|
130
ConocoPhillips
COP
$141B
| $20M | 0.14% |
475,423
-202,786
| -30% | -$8.2M |
|
131
BioMarin Pharmaceuticals
BMRN
$11.6B
| $19.7M | 0.14% |
159,791
-1,500
| -0.9% | -$149K |
|
132
Oracle
ORCL
$345B
| $19.6M | 0.14% |
353,744
-96,230
| -21% | -$5.1M |
|
133
Labcorp
LH
$24.7B
| $19.3M | 0.14% |
135,301
-227,378
| -63% | -$31.5M |
|
134
US Bancorp
USB
$98.9B
| $19M | 0.13% |
515,675
-280,282
| -35% | -$9.99M |
|
|
135
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$781B
| $19M | 0.13% |
+61,500
| New | +$18M |
|
|
NEE.PRP
136
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $18.7M | 0.13% |
440,890
-640
| -0.1% | -$27.6K |
|
137
Crown Castle
CCI
$32.4B
| $18M | 0.13% |
107,364
+45,257
| +73% | +$7.29M |
|
|
SOLN
138
DELISTED
The Southern Company
SOLN
| $17.6M | 0.12% |
400,000
| – | – |
|
139
Caterpillar
CAT
$402B
| $17.5M | 0.12% |
138,309
-8,784
| -6% | -$1.04M |
|
140
GE Aerospace
GE
$375B
| $17M | 0.12% |
500,035
-17,829
| -3% | -$601K |
|
141
Equinix
EQIX
$103B
| $16.9M | 0.12% |
24,120
+10,988
| +84% | +$7.43M |
|
|
COUP
142
DELISTED
Coupa Software Incorporated
COUP
| $16.8M | 0.12% |
60,701
+20,520
| +51% | +$4.13M |
|
143
American Express
AXP
$229B
| $16.4M | 0.12% |
171,780
-6,409
| -4% | -$590K |
|
144
NextEra Energy
NEE
$185B
| $16.3M | 0.12% |
271,420
-16,712
| -6% | -$1M |
|
145
Charter Communications
CHTR
$15.7B
| $16.2M | 0.11% |
31,726
-2,030
| -6% | -$1.03M |
|
|
SCHW
146
Charles Schwab
SCHW
$181B
| $16.2M | 0.11% |
478,898
+25,579
| +6% | +$916K |
|
|
ZEN
147
DELISTED
ZENDESK INC
ZEN
| $15.9M | 0.11% |
179,813
-88,154
| -33% | -$6.79M |
|
148
Southwest Airlines
LUV
$22.2B
| $15.8M | 0.11% |
462,371
+335,429
| +264% | +$10.7M |
|
149
Kinder Morgan
KMI
$70.6B
| $15.7M | 0.11% |
1,032,122
+305,830
| +42% | +$4.65M |
|
150
Altria Group
MO
$122B
| $15.5M | 0.11% |
394,887
-21,509
| -5% | -$839K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.
- Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
- Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
- Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
- Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
- Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
- Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
- Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.
Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.